Zoetis stock dips after FDA notice on Librela (ZTS:NYSE)

- FDA Warns About Dangers of Dog Pain Drug
Agency reviews thousands of cases of side effects, including deaths, reported for dogs that took Librela.
from: WSJ

- Zoetis Responds to FDA’s ‘Dear Veterinarian’ Letter
The U.S. Food and Drug Administration has issued a “Dear Veterinarian” letter notifying practitioners about adverse events reported in dogs...
from: Today's Veterinary Business

- FDA Warns About Dangers of Dog Pain Drug
The agency said it had reviewed more than 3600 cases of side effects, including deaths, reported for dogs that took the drug Librela.
from: Yahoo

- FDA Warns About Dangers of Dog Pain Drug
Agency reviews thousands of cases of side effects, including deaths, reported for dogs that took Librela.
from: WSJ

- Zoetis Responds to FDA’s ‘Dear Veterinarian’ Letter
The U.S. Food and Drug Administration has issued a “Dear Veterinarian” letter notifying practitioners about adverse events reported in dogs...
from: Today's Veterinary Business

- The ‘miracle drug’ some dog owners regret using
For the best listening experience and to never miss an episode, subscribe to The Decibel on your favourite podcast app or platform: Apple...
from: The Globe and Mail

- FDA Warns About Dangers of Dog Pain Drug
The agency said it had reviewed more than 3600 cases of side effects, including deaths, reported for dogs that took the drug Librela.
from: Yahoo

Adverse event, Center for Veterinary Medicine, Dog, Food and Drug Administration, Zoetis